Listen to Expert Faculty discuss the paradigm shift for cardiologists in understanding how to use SGLT2i’s and GLP-1RA’s safely and effectively in their practice. This discussion focuses on when and how to safely commence these drugs, as well as when and how to engage other members of the care team.

Faculty:

Christopher Granger, MD, FACC
Professor of Medicine, Director, Cardiac Intensive Care Unit, Duke University Medical Center

Adam Nelson, MBBS
Duke Clinical Research Institute

Neha Pagidipati, MD
Assistant Professor of Medicine, Duke University Medical Center

Robert Eckel, MD
Professor of Medicine, Emeritus, University of Colorado Anschutz Medical Campus

Educational grant support provided by: Boehringer Ingelheim Lilly